open access

Vol 10, No 3 (2005)
Original Paper
Published online: 2005-01-01
Submitted: 2004-02-26
Get Citation

An assessment of the value of Stereotactic Mammotomy Biopsy (SMB) in the diagnosis of impalpable breast lesions

Paweł Murawa, Anna Pawelska, Robert Kobylarek, Mohsen Nasher
DOI: 10.1016/S1507-1367(05)71084-1
·
Rep Pract Oncol Radiother 2005;10(3):125-129.

open access

Vol 10, No 3 (2005)
Original Paper
Published online: 2005-01-01
Submitted: 2004-02-26

Abstract

Background

Breast cancer is the most common malignancy for women in Poland and represents 19.7% of all neoplasms diagnosed in this group. It is also the most frequent cause of cancer related deaths among women (14.1% of total).

An improvement in these results has been achieved by the popularisation of prophylactic mammography. An increase in awareness among women, of the dangers of breast cancer, and an increase in the availability of mammography testing has resulted in impalpable breast lesions being diagnosed increasingly frequently. These diagnoses require histopathological verification.

Aim

To demonstrate the usefulness of stereotactic mammotomy biopsy (SMB)in the diagnosis of impalpable breast lesions, and its effects on the processes of diagnosis, classification and treatment of pre-invasive growths within the breast.

Materials/Methods

Stereotactic mammotomy biopsy is a minimally invasive method for the collection of tissue from impalpable changes in the breast which are visible in mammography images and require histopathological diagnosis. The procedure may be carried out on an ambulant patients, under a local anaesthetic.

Between April, 2000, and August, 2003, the First Surgical Department carried out 2000 SMB procedures. Changes suitable for biopsy fall into three groups: clusters and areas of microcalcification – 929 (46.45%), small tumours and soft tissue density – 975 (48.75%), radial structures – 96 (4.80%).

Results

365 patients (18.25%)required surgery for the purpose of obtaining a histopathological diagnosis, including 150 (7.50%)with invasive cancer, 120 (6.00%)with preinvasive cancer – DCIS and 95 (4.75%)with atypical ductal hyperplasia – ADH.

Among the remaining 1635 patients (81.75%)changes were found to be benign and the patients avoided surgery.

Conclusions

It is demonstrated that stereotactic mammotomy biopsy is the method of choice for the diagnosis of mammographically detected, inpalpable lesions of the breast, and furthermore, contributes to the process of diagnosis, classification and treatment of pre-invasive growths in the breast.

Abstract

Background

Breast cancer is the most common malignancy for women in Poland and represents 19.7% of all neoplasms diagnosed in this group. It is also the most frequent cause of cancer related deaths among women (14.1% of total).

An improvement in these results has been achieved by the popularisation of prophylactic mammography. An increase in awareness among women, of the dangers of breast cancer, and an increase in the availability of mammography testing has resulted in impalpable breast lesions being diagnosed increasingly frequently. These diagnoses require histopathological verification.

Aim

To demonstrate the usefulness of stereotactic mammotomy biopsy (SMB)in the diagnosis of impalpable breast lesions, and its effects on the processes of diagnosis, classification and treatment of pre-invasive growths within the breast.

Materials/Methods

Stereotactic mammotomy biopsy is a minimally invasive method for the collection of tissue from impalpable changes in the breast which are visible in mammography images and require histopathological diagnosis. The procedure may be carried out on an ambulant patients, under a local anaesthetic.

Between April, 2000, and August, 2003, the First Surgical Department carried out 2000 SMB procedures. Changes suitable for biopsy fall into three groups: clusters and areas of microcalcification – 929 (46.45%), small tumours and soft tissue density – 975 (48.75%), radial structures – 96 (4.80%).

Results

365 patients (18.25%)required surgery for the purpose of obtaining a histopathological diagnosis, including 150 (7.50%)with invasive cancer, 120 (6.00%)with preinvasive cancer – DCIS and 95 (4.75%)with atypical ductal hyperplasia – ADH.

Among the remaining 1635 patients (81.75%)changes were found to be benign and the patients avoided surgery.

Conclusions

It is demonstrated that stereotactic mammotomy biopsy is the method of choice for the diagnosis of mammographically detected, inpalpable lesions of the breast, and furthermore, contributes to the process of diagnosis, classification and treatment of pre-invasive growths in the breast.

Get Citation

Keywords

stereotactic biopsy; subclinical breast cancer

About this article
Title

An assessment of the value of Stereotactic Mammotomy Biopsy (SMB) in the diagnosis of impalpable breast lesions

Journal

Reports of Practical Oncology and Radiotherapy

Issue

Vol 10, No 3 (2005)

Pages

125-129

Published online

2005-01-01

DOI

10.1016/S1507-1367(05)71084-1

Bibliographic record

Rep Pract Oncol Radiother 2005;10(3):125-129.

Keywords

stereotactic biopsy
subclinical breast cancer

Authors

Paweł Murawa
Anna Pawelska
Robert Kobylarek
Mohsen Nasher

Important: This website uses cookies. More >>

The cookies allow us to identify your computer and find out details about your last visit. They remembering whether you've visited the site before, so that you remain logged in - or to help us work out how many new website visitors we get each month. Most internet browsers accept cookies automatically, but you can change the settings of your browser to erase cookies or prevent automatic acceptance if you prefer.

By "Via Medica sp. z o.o." sp.k., ul. Świętokrzyska 73, 80–180 Gdańsk, Poland
tel.:+48 58 320 94 94, fax:+48 58 320 94 60, e-mail: journals@viamedica.pl